Controversy over neonatal drug testing may be due to a lack of agreeme
nt on the purposes for such testing. This article examines six issues:
(1) the purpose of neonatal testing; (2) the selection of infants for
testing; (3) the requirement for parental consent; (4) the concept of
prenatal harm; (5) the standard of conduct required of a pregnant wom
an; and (6) the practical application of such a standard in designing
a-testing policy. It is argued that maternal consent does not need to
be required for testing provided that: (1) adequate drug treatment ser
vices are available for the mother and infant; and (2) test results ar
e excluded from use in legal proceedings. If prevention, therapy and r
esearch (rather than punishment) guides a neonatal testing policy, the
sporadic testing of an infant's urine for the presence of illicit sub
stances clearly falls short of the desired goals.